CClinicalTrials.gg
RecruitingNCT05377151Updated Sep 15, 2023

Effectiveness of mHealth Education on Health Outcomes Among Pregnant Women

An interventional study of Mobile application in Pregnant Women, sponsored by Universiti Putra Malaysia. Recruiting at 3 sites in Malaysia. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-15.

Sponsored by Universiti Putra Malaysia · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years ago, but the record still lists the study as recruiting.
  • Started Apr 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
294
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Gestational weight gain (GWG), weight gain of a mother during pregnancy, is an important determinant that influence the health outcomes of mothers and fetus. There is an increasing trend of pregnant women using mobile health (mHealth) to assess for pregnancy-related health information. While evidence on the effectiveness of mHealth education on improving pregnancy outcomes among pregnant women is growing, the findings had been inconclusive with scarcity of such data in Malaysia. The objective of the study is to determine the effectiveness of a 9-month mHealth intervention on GWG and other outcomes (prenatal knowledge, physical activity, psychosocial well-being, nutritional status, quality of life and sleep quality) among pregnant women.

Read the detailed description

This study will evaluate the usability, feasibility and practicality of a previously developed smartphone application with complete alpha and beta testing on pregnancy outcomes in a cluster randomised control trial (RCT).

The study will be completed by involving the nutrition intervention using either mHealth interventions or conventional methods that will be carried out among pregnancy women.

Subjects will be allocated into groups according to respective health clinics, namely, two interventions group which are:

Group 1: mHealth intervention group

Group 2: mHealth intervention group + dietitian consultation

Group 3: control group

which total of 294 eligible subjects will be recruited, with 98 subjects are needed in respective groups.

This is a cluster-randomised controlled trial. For Malaysia consist of two regions which are East Malaysia and West (or peninsular) Malaysia and they are actually about 400 miles (640 km) apart. At East Malaysia, we targeted on the area with higher density of population which are Klang Valley (Kuala Lumpur, Selangor and Putrajaya). As shown in Figure 1, for three states under Klang Valley, we obtained ethics approval from the Jabatan Kesihatan Negeri Selangor for Selangor state and Jabatan Kesihatan Wilayah Persekutuan Kuala Lumpur dan Putrajaya for Putrajaya state. In order to prevent cross contamination between the states, we use simple random sampling which Selangor been allocated into control group and Putrajaya as intervention group.

As under Putrajaya states only two clinics granted approval for data collection which are Presint 9 Health Clinic and Presint 18 Health Clinic. By using cluster sampling method, Presint 9 Health Clinic was randomised into intervention group 1 which whole cluster participant will be receiving mHealth intervention alone and Presint 18 Health Clinic into intervention group 2 which whole cluster participants will receive mHealth intervention group in addition with personal dietitian consultation.

There are nine districts in Selangor: Gombak, Hulu Langat, Hulu Selangor, Klang, Kuala Langat, Kuala Selangor, Petaling, Sabak Bernam and Sepang which consist of total of 81 health clinics, we stratified the number of health clinics within the 25 km radius from the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia due to the geographical proximity and financial constraints (limited budget). There were total of 15 health clinics after stratification and simple random sampling was done which Seri Kembangan health clinics in Petaling District had been chosen as control group. As this is an intervention study, thus blinding is not applicable for data collection personnel and participants. The health clinics that involved in this study will be maternal and child health clinics.

This study will use a set of questionnaires to obtain information on personal information, anthropometry data, prenatal knowledge, physical activity, psychosocial well-being, dietary intake, quality of life, sleep quality and gestational weight gain of the subjects, based on appropriate instruments. Re-assessment will be performed at month-6 and month-9 (delivery) after baseline measurements. During the re-assessment, the data will be collected again on dietary intake, physical activity, psychosocial well-being, sleep quality and quality of life. All subjects will be followed up prospectively until delivery. The follow up data collection will be matched with the prenatal visit of the pregnant mother to the clinic.

02

Conditions studied

  • Pregnant Women

Keywords

  • Pregnant mother
  • Mobile health (mHealth)
  • Nutrition and diet
  • Gestational Weight Gain
  • Quality of Life
  • Pregnancy outcomes
03

In context

Lead sponsor

Universiti Putra Malaysia is the lead sponsor of 144 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Malaysian women
  • 18 - 40 years old
  • Single pregnancy
  • At first trimester or second trimester
  • All ethnicities
  • Meet or did not meet with dietitian before
  • With or without diseases (diabetes mellitus with/ without low dose insulin, hypertension, hyperlipidaemia, overweight/ obese)
  • Own smart phone with internet access
  • All BMI categories

Exclusion criteria

Exclusion Criteria:

  • Diagnosed by medical doctor with major psychiatric problems (bipolar depression, schizophrenia, suicidal risk)
  • Multiple pregnancies
  • On other intervention program
  • Grand multipara
  • Severe comorbidities (cardiac diseases, severe anaemia)
  • Type 1 diabetes mellitus or Type 2 diabetes mellitus with high dose insulin
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
294 participants (estimated)

Study arms

  • Experimental
    mobile application (mHealth) intervention only

    - the subjects will receive mobile application (mHealth) intervention only

    Other: Mobile application

  • Experimental
    mobile application (mHealth) intervention and dietitian consultation

    - the subjects will receive the information from both mobile application (mHealth) and dietitian consultation

    Other: Mobile application

  • No intervention
    standard usual care- dietitian consultation

    - the subjects will receive all the related information from the standard usual care- dietitian consultation

Interventions

  • OtherMobile application

    Nutrition intervention using either mHealth interventions or conventional methods will be carried out among pregnant women). Subjects will be allocated into three groups, namely, two interventions group which are: Group 1: mHealth intervention group (98 subjects) Group 2: mHealth intervention group + dietitian consultation (98 subjects) Group 3: control group (98 subjects)

06

What researchers measure

Primary outcomes

  1. Changes in Gestational Weight Gain

    Weight gain (kg)

    Time frame: 3 points time (Baseline, 6th month, 9th month/ delivery)

Secondary outcomes

  1. Prenatal knowledge

    The maternal health literacy inventory in pregnancy (MHELIP) MHELIP score to 4 categories: 'inadequate', 'problematic' (which together also define 'limited' health literacy), 'sufficient and 'excellent' (which together also defined 'desired' health literacy): Inadequate= 0-50 Problematic= 50.1-66 Sufficient= 66.1-84 Excellent=84.1-100

    Time frame: 1 point1 time (Baseline)

  2. Physical activity

    Pregnancy Physical Activity Questionnaire (PPAQ) The activity was classified by intensity: sedentary (\< 1.5 METs), light (1.5- \< 3.0 METs), moderate (3.0-6.0 METs) or vigorous (\> 6.0 METs) and the average number of MET-hours per week expended in each intensity level was calculated. The higher the score, the more active the subject is.

    Time frame: 2 points time (Baseline, 6th month)

  3. Psychosocial well-being

    Depression Anxiety and Stress Scale (DASS-21) Scores on the DASS-21 will need to be multiplied by 2 to calculate the final score. Depression (Normal: 0-9; Mild: 10-13; Moderate: 14-20; Severe: 21-27; Extremely Severe: 28+) Anxiety (Normal: 0-7; Mild: 8-9; Moderate: 10-14; Severe: 15-19; Extremely Severe: 20+) Stress (Normal: 0-14; Mild: 15-18; Moderate: 19-25; Severe: 26-33; Extremely Severe: 34+)

    Time frame: 3 points time (Baseline, 6th month, 9th month/ delivery)

  4. Nutritional status

    24-hour dietary recall (2 weekdays and 1 weekend)

    Time frame: 3 points time (Baseline, 6th month, 9th month/ delivery)

  5. Quality of life (well being)

    WHO 5 item well being index The raw score is calculated by totalling the figures of the five answers. The raw score ranges from 0 to 25, 0 representing worst possible and 25 representing best possible quality of life. To obtain a percentage score ranging from 0 to 100, the raw score is multiplied by 4. A percentage score of 0 represents worst possible, whereas a score of 100 represents best possible quality of life.

    Time frame: 3 points time (Baseline, 6th month, 9th month/ delivery)

  6. Sleep quality

    Pittsburgh Sleep Quality Index (PSQI) In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.

    Time frame: 3 points time (Baseline, 6th month, 9th month/ delivery)

  7. Pregnancy outcome (Type of delivery)

    Spontaneous vaginal delivery (SVD): Cephalic/ Breech/ Assisted Breech; Instrumental Delivery: Forceps/ Vacuum; Caesarean: Elective/ Emergency/ Lower segment Caesarean section (LSCS)/ Classical

    Time frame: 1 point time (9th month/ delivery)

  8. Pregnancy outcome (Apgar Score)

    @1 minute and @5 minutes (Apgar Score 7-10: Good outcome)

    Time frame: 1 point time (9th month/ delivery)

  9. Pregnancy outcome (Born term)

    Yes / No (_______ week)

    Time frame: 1 point time (9th month/ delivery)

  10. Pregnancy outcome (Infant weight)

    weight (kg)

    Time frame: 1 point time (9th month/ delivery)

  11. Pregnancy outcome (Infant length)

    length (cm)

    Time frame: 1 point time (9th month/ delivery)

  12. Pregnancy outcome (Infant head circumference)

    head circumference (cm)

    Time frame: 1 point time (9th month/ delivery)

  13. Pregnancy outcome ( Infant breast circumference)

    breast circumference (cm)

    Time frame: 1 point time (9th month/ delivery)

  14. Pregnancy outcome (Infant gender)

    Male/ Female

    Time frame: 1 point time (9th month/ delivery)

  15. Pregnancy outcome (Maternal complications)

    Postpartum hemorrhage (PPH)/ Eklampsia / Retained placenta/ Venous thromboembolism (VTE)/ Postpartum depression

    Time frame: 1 point time (9th month/ delivery)

  16. Pregnancy outcome (Infant complications)

    Miscarriage/ Prematurity/ Stillbirth/ Congenital anomalies/ Shoulder dystosia/ Jaundice / Respiratory related / Transient Tacypnoiec of newborn (TTN)/ Pneumonia (lung infection)

    Time frame: 1 point time (9th month/ delivery)

07

Study locations

3 of 3 sites recruiting
  • Seri Kembangan Health Clinic
    Seri Kembangan, Selangor 43300, Malaysia
    Recruiting
  • Presint 18 Health Clinic
    Putrajaya, Malaysia
    Recruiting
  • Presint 9 Health Clinic
    Putrajaya, Malaysia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05377151
Lead sponsor
Universiti Putra Malaysia
Responsible party
Chan Yoke Mun (Professor, Universiti Putra Malaysia) — Principal investigator
First posted
May 17, 2022
Start date
Apr 1, 2023
Primary completion
Sep 30, 2023 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Sep 15, 2023

Study contacts

Yoke Mun Chan
Contact
cym@upm.edu.my
03-97692433
Yoke Mun Chan
principal investigator · Universiti Putra Malaysia

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion